Brexit: fully prepared
The United Kingdom (UK) is leaving the European Union in March 2019. The terms on which the UK is going to leave the EU are still unclear. The main priority for the Medicines Evaluation Board (MEB) is that the quality, safety and efficacy of medicinal products must not be allowed to suffer as a result of Brexit. For that reason the MEB is making preparations to cope as best as possible with the consequences of Brexit.